Apixaban to Prevent Infarcts After Stroke in Patients With Atrial Cardiopathy
This secondary analysis of a parallel-design double-blind secondary stroke prevention trial in patients with cryptogenic stroke and atrial cardiopathy evaluates the association between apixaban and the incidence of covert infarcts.